Medexus Pharmaceuticals Inc. (MEDXF)

Medexus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	69	29	24	50	120	25
Market Cap Growth	5.60%	21.85%	-52.44%	-58.30%	390.26%	-49.66%
Enterprise Value	103	72	80	94	162	27
Last Close Price	2.80	1.22	1.19	2.51	6.30	2.00
PE Ratio	29.94	-	19.55	-	-	-
PS Ratio	0.46	0.26	0.22	0.65	1.51	0.44
PB Ratio	1.47	0.96	1.06	2.82	6.68	1.01
P/FCF Ratio	2.18	1.56	-	-	24.45	-
P/OCF Ratio	2.17	1.55	-	-	23.88	-
EV/Sales Ratio	1.04	0.64	0.74	1.23	2.04	0.49
EV/EBITDA Ratio	5.85	3.91	5.59	-	25.52	11.14
EV/EBIT Ratio	8.50	5.64	9.46	-	221.81	-
EV/FCF Ratio	4.64	3.86	-	-	32.94	-
Debt / Equity Ratio	1.31	1.65	3.12	3.08	2.49	1.60
Debt / EBITDA Ratio	2.31	2.68	4.81	-	6.69	13.91
Debt / FCF Ratio	1.94	2.67	-	-	9.11	-
Asset Turnover	0.67	0.71	0.72	0.53	0.59	0.55
Inventory Turnover	1.40	1.79	1.92	1.83	2.24	2.31
Quick Ratio	0.32	0.44	0.42	0.51	0.94	0.59
Current Ratio	1.01	1.09	0.87	1.02	1.47	1.16
Return on Equity (ROE)	8.42%	-0.81%	6.07%	-16.08%	-133.65%	-18.55%
Return on Assets (ROA)	5.14%	5.04%	3.53%	-5.38%	0.34%	-0.70%
Return on Capital (ROIC)	9.45%	9.25%	6.42%	-11.41%	0.73%	-1.35%
Earnings Yield	3.34%	-0.74%	5.12%	-5.74%	-23.48%	-19.15%
FCF Yield	32.19%	64.18%	-6.31%	-2.54%	4.09%	-7.36%
Buyback Yield / Dilution	-18.66%	-9.56%	-3.36%	-30.65%	-5.83%	-44.92%
Total Shareholder Return	-18.66%	-9.56%	-3.36%	-30.65%	-5.83%	-44.92%

Source: S&P Capital IQ. Standard template. Financial Sources.